OnRamp Bioinformatics, Inc. offers the ROSALIND platform, which lets scientists analyze next-generation sequencing data without coding.
Founded in 2013 and headquartered in San Diego, US, OnRamp Bioinformatics, Inc. provides the ROSALIND discovery platform and data hub for next-generation sequencing analysis, used by academic and industry scientists. It is sold through tiered Enterprise, Professional and Academic subscriptions, typically annual or multi-year. Tim Wesselman serves as CEO, and the company raised funding in October 2018 from Pasadena Angels, Tech Coast Angels and Wavemaker Three-Sixty Health.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in